Thermo Fisher Scientific announced an expansion of its bioprocessing capabilities across Asia. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network designed to enhance speed, efficiency and sustainability in biomanufacturing.
Asia is an emerging global hub for biopharmaceutical innovation, driven by increased demand for biologics, vaccines and cell and gene therapies. Thermo Fisher’s continued investment across the region supports this growth, enabling customers with access to world-class technologies, expertise and localized support to accelerate the delivery of life-changing therapies.
“Asia continues to play an increasingly important role in advancing innovation across the global biopharma industry,” said Daniella Cramp, Senior Vice President and President, BioProduction at Thermo Fisher Scientific. “By expanding our network in Korea, Singapore and India, we’re bringing world-class infrastructure and expertise closer to our customers, helping them deliver high-quality biologics faster, more cost-effectively and more sustainably.”
Thermo Fisher’s tri-hub network connects leading Bioprocess Design Centers in Incheon, Hyderabad and Singapore, accelerates process development and brings Thermo Fisher’s world-class expertise closer to customers throughout Asia.
- Incheon, Korea: The newly expanded Bioprocess Design Center empowers deeper collaboration and innovation through advanced materials, technologies, and enhanced lab capabilities.
- Hyderabad, India (Genome Valley): The new Bioprocess Design Center, developed in partnership with the Government of Telangana, offers collaborative spaces for process design, simulation and optimization. It enables customers to co-create and test bioprocesses using the latest single-use and hybrid systems, advancing India’s rapidly growing biomanufacturing ecosystem.
- Singapore: This expanded facility provides access to bench-to-pilot scale bioprocessing, expert-led training and deep collaborations with Thermo Fisher’s technical teams to scale early-stage processes, supporting flexible and sustainable biomanufacturing.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!